{"id":404979,"date":"2020-12-23T06:33:15","date_gmt":"2020-12-23T11:33:15","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=404979"},"modified":"2020-12-23T06:33:15","modified_gmt":"2020-12-23T11:33:15","slug":"khiron-provides-year-end-corporate-update","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/khiron-provides-year-end-corporate-update\/","title":{"rendered":"Khiron Provides Year-End Corporate Update"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <b>T<\/b>ORONTO, <span class=\"xn-chron\">Dec. 23, 2020<\/span> \/PRNewswire\/ &#8211; Khiron Life Sciences Corp. (&#8220;Khiron&#8221; or the &#8220;Company&#8221;) (TSXV: <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3021264-1&amp;h=2449845057&amp;u=https%3A%2F%2Fwww.newswire.ca%2Fnews-releases%2Fkhiron-life-sciences-to-present-as-lead-sponsor-in-first-cannatech-panama-global-medical-cannabis-summit-816331667.html%23financial-modal&amp;a=KHRN\" rel=\"nofollow noopener noreferrer\">KHRN<\/a>) (OTCQX: KHRNF) (<span class=\"xn-location\">Frankfurt<\/span>: A2JMZC), a vertically integrated cannabis leader with core operations in <span class=\"xn-location\">Latin America<\/span> and <span class=\"xn-location\">Europe<\/span>, provides a year-end corporate update on its global operations. <\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/1391118\/Khiron_Life_Sciences_Corp__Khiron_Provides_Year_End_Corporate_Up.html\" target=\"_blank\" rel=\"nofollow noopener noreferrer\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/1391118\/Khiron_Life_Sciences_Corp__Khiron_Provides_Year_End_Corporate_Up.jpg\" title=\"Khiron Life Sciences Corp. logo (CNW Group\/Khiron Life Sciences Corp.)\" alt=\"Khiron Life Sciences Corp. logo (CNW Group\/Khiron Life Sciences Corp.)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>\n        <b><br \/>\n          <span class=\"xn-location\">Colombia<\/span><br \/>\n        <\/b>\n      <\/p>\n<ul type=\"disc\">\n<li>Khiron is the first cannabis company in <span class=\"xn-location\">Colombia<\/span> to ship THC products internationally <\/li>\n<li>Colombian government extends medical health insurance coverage to THC and CBD medical cannabis products <\/li>\n<li>Company appoints former <span class=\"xn-location\">Colombia<\/span> Minister of Finance <span class=\"xn-person\">Juan Carlos Echeverry<\/span> as an independent member of its Board of Directors <\/li>\n<li>On <span class=\"xn-chron\">December 9<\/span><sup>th<\/sup>, Khiron opens new small-format clinic in <span class=\"xn-location\">Medellin, Colombia&#8217;s<\/span> 2<sup>nd<\/sup>\u00a0largest city, as part of the Company&#8217;s plan to extend its medical cannabis clinics across <span class=\"xn-location\">Colombia<\/span> and <span class=\"xn-location\">Latin America<\/span><\/li>\n<li>Khiron declared a National Strategic Project by the Government of <span class=\"xn-location\">Colombia<\/span>, which simplifies and accelerates administration processes for the Company&#8217;s strategic initiatives <\/li>\n<li>Doctor Zerenia<sup>TM<\/sup>\u00a0telehealth platform attracts 25% of patients from outside of <span class=\"xn-location\">Bogota<\/span>, expanding national reach <\/li>\n<li>Patient consultations at Company owned clinics return to pre COVID-19 levels<\/li>\n<\/ul>\n<p>\u00a0<b><span class=\"xn-location\">Peru<\/span><\/b><\/p>\n<ul type=\"disc\">\n<li>Company becomes the first private medical cannabis company to sell both THC and CBD medical cannabis products in <span class=\"xn-location\">Peru<\/span>. In doing so, it also becomes the first company to ever export THC from <span class=\"xn-location\">Colombia<\/span> for commercial purposes\u00a0<\/li>\n<\/ul>\n<p>\n        <b><br \/>\n          <span class=\"xn-location\">Europe<\/span><br \/>\n        <\/b>\n      <\/p>\n<ul type=\"disc\">\n<li>Khiron ships medical cannabis products to the UK for Project Twenty21, which now has more than 8,000 patients who have registered their interest <\/li>\n<li>Company&#8217;s medical cannabis e-learning certification completed by physicians participating in partnership with the UK&#8217;s Medical Cannabis Clinicians Society <\/li>\n<\/ul>\n<p>&#8220;This has been an historic year for Khiron in the advancement of our business; We are seeing patient volume in our expanding network of clinics in <span class=\"xn-location\">Colombia<\/span>, our telehealth platform is attracting patients across the country, and with sales in <span class=\"xn-location\">Peru<\/span> we are the first company ever to export THC product from <span class=\"xn-location\">Colombia<\/span>. \u00a0The global pandemic has made 2020 challenging for the Company, and at times we have had to suspend certain clinic medical services, however, as we look to 2021 in a position of operational and financial strength, I would like to recognize the remarkable hard work, dedication and commitment of our global team,&#8221; comments <span class=\"xn-person\">Alvaro Torres<\/span>, Khiron CEO and Director. <\/p>\n<p>\n        <b>About Khiron Life Sciences Corp.<\/b>\n      <\/p>\n<p>Khiron is a vertically integrated medical and CPG cannabis company with core operations in <span class=\"xn-location\">Latin America<\/span>, and operational activity in <span class=\"xn-location\">Europe<\/span> and North America.\u00a0 Khiron is the leading cannabis company in <span class=\"xn-location\">Colombia<\/span> and the first company licensed in <span class=\"xn-location\">Colombia<\/span> for the cultivation, production, domestic distribution and sales, and international export of both low and high THC medical cannabis products. The Company has filled medical cannabis prescriptions in <span class=\"xn-location\">Peru<\/span> and has a presence in <span class=\"xn-location\">Mexico<\/span>, <span class=\"xn-location\">Uruguay<\/span>, UK, <span class=\"xn-location\">Spain<\/span> and also in <span class=\"xn-location\">Germany<\/span>, where it is positioned to begin sales of medical cannabis.<\/p>\n<p>Leveraging its first-mover advantage and patient-oriented approach, Khiron combines global scientific expertise, product innovation, agricultural infrastructure, wholly-owned medical clinics, and online doctor education programs to drive prescription and brand loyalty to address priority medical conditions. Its Wellbeing unit launched the first branded CBD skincare brand in <span class=\"xn-location\">Colombia<\/span>, with Kuida<sup>TM<\/sup> now marketed in multiple jurisdictions in <span class=\"xn-location\">Latin America<\/span>, the US and UK. The Company is led by Co-founder and Chief Executive Officer, <span class=\"xn-person\">Alvaro Torres<\/span>, together with an experienced and diverse executive team and Board of Directors.<\/p>\n<p>Visit Khiron online at <a target=\"_blank\" href=\"\/\/\/Users\/lmarquez\/AppData\/Local\/Microsoft\/Windows\/INetCache\/Content.Outlook\/53B6PFRV\/investors.khiron.ca\" rel=\"nofollow noopener noreferrer\">investors.khiron.ca<\/a> and on Instagram @khironlife.<\/p>\n<p>Cautionary Notes<\/p>\n<p>\n        <b>Forward-Looking Statements<\/b>\n      <\/p>\n<p>This press release may contain certain &#8220;forward-looking information&#8221; and &#8220;forward-looking statements&#8221; within the meaning of applicable securities legislation. All information contained herein that is not historical in nature may constitute forward-looking information. Khiron undertakes no obligation to comment on analyses, expectations or statements made by third-parties in respect of Khiron, its securities, or financial or operating results (as applicable). Although Khiron believes that the expectations reflected in forward-looking statements in this press release are reasonable, such forward-looking statement has been based on expectations, factors and assumptions concerning future events which may prove to be inaccurate and are subject to numerous risks and uncertainties, certain of which are beyond Khiron&#8217;s control, including the risk factors discussed in Khiron&#8217;s Annual Information Form which is available on Khiron&#8217;s SEDAR profile at <a href=\"http:\/\/www.sedar.com\" rel=\"nofollow\">www.sedar.com<\/a>. The forward-looking information contained in this press release is expressly qualified by this cautionary statement and is made as of the date hereof. Khiron disclaims any intention and has no obligation or responsibility, except as required by law, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise.<\/p>\n<p>Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this press release.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder2\"><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=TO32456&amp;sd=2020-12-23\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"http:\/\/www.prnewswire.com\/news-releases\/khiron-provides-year-end-corporate-update-301198033.html\">http:\/\/www.prnewswire.com\/news-releases\/khiron-provides-year-end-corporate-update-301198033.html<\/a><\/p>\n<p>SOURCE  Khiron Life Sciences Corp.<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=TO32456&amp;Transmission_Id=202012230630PR_NEWS_USPR_____TO32456&amp;DateId=20201223\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire TORONTO, Dec. 23, 2020 \/PRNewswire\/ &#8211; Khiron Life Sciences Corp. (&#8220;Khiron&#8221; or the &#8220;Company&#8221;) (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, provides a year-end corporate update on its global operations. Colombia Khiron is the first cannabis company in Colombia to ship THC products internationally Colombian government extends medical health insurance coverage to THC and CBD medical cannabis products Company appoints former Colombia Minister of Finance Juan Carlos Echeverry as an independent member of its Board of Directors On December 9th, Khiron opens new small-format clinic in Medellin, Colombia&#8217;s 2nd\u00a0largest city, as part of the Company&#8217;s plan to extend its medical cannabis clinics across Colombia and Latin &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/khiron-provides-year-end-corporate-update\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Khiron Provides Year-End Corporate Update&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-404979","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Khiron Provides Year-End Corporate Update - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/khiron-provides-year-end-corporate-update\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Khiron Provides Year-End Corporate Update - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire TORONTO, Dec. 23, 2020 \/PRNewswire\/ &#8211; Khiron Life Sciences Corp. (&#8220;Khiron&#8221; or the &#8220;Company&#8221;) (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, provides a year-end corporate update on its global operations. Colombia Khiron is the first cannabis company in Colombia to ship THC products internationally Colombian government extends medical health insurance coverage to THC and CBD medical cannabis products Company appoints former Colombia Minister of Finance Juan Carlos Echeverry as an independent member of its Board of Directors On December 9th, Khiron opens new small-format clinic in Medellin, Colombia&#8217;s 2nd\u00a0largest city, as part of the Company&#8217;s plan to extend its medical cannabis clinics across Colombia and Latin &hellip; Continue reading &quot;Khiron Provides Year-End Corporate Update&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/khiron-provides-year-end-corporate-update\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-23T11:33:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/1391118\/Khiron_Life_Sciences_Corp__Khiron_Provides_Year_End_Corporate_Up.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/khiron-provides-year-end-corporate-update\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/khiron-provides-year-end-corporate-update\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Khiron Provides Year-End Corporate Update\",\"datePublished\":\"2020-12-23T11:33:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/khiron-provides-year-end-corporate-update\\\/\"},\"wordCount\":793,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/khiron-provides-year-end-corporate-update\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1391118\\\/Khiron_Life_Sciences_Corp__Khiron_Provides_Year_End_Corporate_Up.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/khiron-provides-year-end-corporate-update\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/khiron-provides-year-end-corporate-update\\\/\",\"name\":\"Khiron Provides Year-End Corporate Update - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/khiron-provides-year-end-corporate-update\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/khiron-provides-year-end-corporate-update\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1391118\\\/Khiron_Life_Sciences_Corp__Khiron_Provides_Year_End_Corporate_Up.jpg\",\"datePublished\":\"2020-12-23T11:33:15+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/khiron-provides-year-end-corporate-update\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/khiron-provides-year-end-corporate-update\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/khiron-provides-year-end-corporate-update\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1391118\\\/Khiron_Life_Sciences_Corp__Khiron_Provides_Year_End_Corporate_Up.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1391118\\\/Khiron_Life_Sciences_Corp__Khiron_Provides_Year_End_Corporate_Up.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/khiron-provides-year-end-corporate-update\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Khiron Provides Year-End Corporate Update\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Khiron Provides Year-End Corporate Update - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/khiron-provides-year-end-corporate-update\/","og_locale":"en_US","og_type":"article","og_title":"Khiron Provides Year-End Corporate Update - Market Newsdesk","og_description":"PR Newswire TORONTO, Dec. 23, 2020 \/PRNewswire\/ &#8211; Khiron Life Sciences Corp. (&#8220;Khiron&#8221; or the &#8220;Company&#8221;) (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, provides a year-end corporate update on its global operations. Colombia Khiron is the first cannabis company in Colombia to ship THC products internationally Colombian government extends medical health insurance coverage to THC and CBD medical cannabis products Company appoints former Colombia Minister of Finance Juan Carlos Echeverry as an independent member of its Board of Directors On December 9th, Khiron opens new small-format clinic in Medellin, Colombia&#8217;s 2nd\u00a0largest city, as part of the Company&#8217;s plan to extend its medical cannabis clinics across Colombia and Latin &hellip; Continue reading \"Khiron Provides Year-End Corporate Update\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/khiron-provides-year-end-corporate-update\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-23T11:33:15+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/1391118\/Khiron_Life_Sciences_Corp__Khiron_Provides_Year_End_Corporate_Up.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/khiron-provides-year-end-corporate-update\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/khiron-provides-year-end-corporate-update\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Khiron Provides Year-End Corporate Update","datePublished":"2020-12-23T11:33:15+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/khiron-provides-year-end-corporate-update\/"},"wordCount":793,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/khiron-provides-year-end-corporate-update\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1391118\/Khiron_Life_Sciences_Corp__Khiron_Provides_Year_End_Corporate_Up.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/khiron-provides-year-end-corporate-update\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/khiron-provides-year-end-corporate-update\/","name":"Khiron Provides Year-End Corporate Update - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/khiron-provides-year-end-corporate-update\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/khiron-provides-year-end-corporate-update\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1391118\/Khiron_Life_Sciences_Corp__Khiron_Provides_Year_End_Corporate_Up.jpg","datePublished":"2020-12-23T11:33:15+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/khiron-provides-year-end-corporate-update\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/khiron-provides-year-end-corporate-update\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/khiron-provides-year-end-corporate-update\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/1391118\/Khiron_Life_Sciences_Corp__Khiron_Provides_Year_End_Corporate_Up.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/1391118\/Khiron_Life_Sciences_Corp__Khiron_Provides_Year_End_Corporate_Up.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/khiron-provides-year-end-corporate-update\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Khiron Provides Year-End Corporate Update"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/404979","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=404979"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/404979\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=404979"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=404979"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=404979"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}